These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3594791)

  • 1. Evaluation of a mid-molecule parathyroid hormone radioimmunoassay.
    Yatscoff RW; Desjardins PR; Krahn J
    Clin Chem; 1987 Jun; 33(6):1074. PubMed ID: 3594791
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-34 Human parathyroid hormone radioimmunoassay: properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application.
    Shiraki M; Kawada N; Akiguchi I; Yamauchi H; Kojima A; Orimo H
    Endocrinol Jpn; 1981 Apr; 28(2):239-44. PubMed ID: 7308159
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of circulating immunoreactive human parathyroid hormone: comparison with a 1-34 N-terminal synthetic fragment.
    Desplan C; Jullienne A; Moukhtar MS; Raulais D; Rivaille P; Milhaud G
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):241-4. PubMed ID: 622389
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating immunoreactive parathyroid hormone in man as evaluated by different radioimmunoassay systems.
    Fischer JA; Hunziker W; Binswanger U; Dambacher MA; Dietrich FM
    Curr Probl Clin Biochem; 1976; 6():249-54. PubMed ID: 1001005
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies against parathyroid hormone in a patient with terminal renal insufficiency.
    Jüppner H; Atkinson MJ; Baethke R; Hesch RD
    Lancet; 1984 Jun; 1(8391):1379-81. PubMed ID: 6145835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological properties of synthetic human parathyroid hormone 53--84 fragment.
    Hendy GN; Manning RM; Rosenblatt M; Tregear GW; Keutmann HT; O'Riordan JL
    J Endocrinol; 1979 Jan; 80(1):153-5. PubMed ID: 429948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of antisera against synthetic 1--34 human parathyroid hormone.
    Visser TJ; Buurman CJ; Hackeng WH; Birkenhäger JC
    J Endocrinol; 1975 Oct; 67(1):141-2. PubMed ID: 1194825
    [No Abstract]   [Full Text] [Related]  

  • 8. A "carboxyl terminal" clinical radioimmunoassay for parathyroid hormone with apparent recognition preference for the intact hormone.
    Hanley DA; Wellings PG
    J Immunoassay; 1985; 6(3):245-59. PubMed ID: 2413077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavage-associated enhancement of an antigenic site in the biologically active NH2-terminal region of parathyroid hormone.
    Habener JF; Potts JT
    Endocrinology; 1979 Jul; 105(1):115-9. PubMed ID: 87321
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological properties of synthetic human parathyroid hormone: effect of deamidation at position 76.
    Gleed JH; Hendy GN; Kimura T; Sakakibara S; O'Riordan JL
    Bone Miner; 1987 Aug; 2(5):375-82. PubMed ID: 2464379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct release of parathyroid hormone fragments from functioning bovine parathyroid glands in vitro.
    Hanley DA; Takatsuki K; Sultan JM; Schneider AB; Sherwood LM
    J Clin Invest; 1978 Dec; 62(6):1247-54. PubMed ID: 748378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Immunological properties of a synthetic 1-34 fragment of human parathyroid hormone.
    Hendy GN; Barling PM; O'Riordan JL
    J Endocrinol; 1974 Nov; 63(2):26P-27P. PubMed ID: 4443686
    [No Abstract]   [Full Text] [Related]  

  • 13. Human parathyroid hormone: immunological properties of the amino terminus and of synthetic fragments.
    Hendy GN; Barling PM; O'Riordan JL
    Clin Sci Mol Med; 1974 Dec; 47(6):567-76. PubMed ID: 4476267
    [No Abstract]   [Full Text] [Related]  

  • 14. Intact parathyroid hormone assay is superior to mid region assay in the EDTA-infusion test in hyperparathyroidism.
    Bergenfelz A; Nordén NE; Ahrén B
    Clin Chim Acta; 1991 Mar; 197(3):229-35. PubMed ID: 1904804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay for the middle region of human parathyroid hormone: studies with a radioiodinated synthetic peptide.
    Marx SJ; Sharp ME; Krudy A; Rosenblatt M; Mallette LE
    J Clin Endocrinol Metab; 1981 Jul; 53(1):76-84. PubMed ID: 7240381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyrin radioimmunoassay: diagnostic utility of antisera produced against carboxyl-terminal fragments of the hormone from the human.
    Di Bella FP; Kehrwald JM; Laakso K; Zitzner L
    Clin Chem; 1978 Mar; 24(3):451-4. PubMed ID: 564762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proceedings: Evaluation of radioimmunoassay of parathyroid hormone: a trial with antibody reacting to N terminal].
    Fujita T; Oata M; Okano K; Yoshikawa M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):592. PubMed ID: 4476596
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fundamental and clinical evaluation of the human parathyroid hormone radioimmunoassay kit (PTH 'Eiken') using antihuman C-terminal (46-84) PTH antibody].
    Noguchi K; Suzuki H; Nakahata M
    Kaku Igaku; 1983 Feb; 20(1):77-82. PubMed ID: 6876495
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heterogeneity of human plasma parathormone].
    Gueris J; Ferriere C
    Pathol Biol (Paris); 1975 Dec; 23(10):821-6. PubMed ID: 772526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous effects of hormone fragments on the measurement of parathyroid hormone by radioimmunoassay.
    Mbuyi-Kalala A; Ehrenstein G
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):87-99. PubMed ID: 8740240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.